IL125913A0 - Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases - Google Patents
Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseasesInfo
- Publication number
- IL125913A0 IL125913A0 IL12591398A IL12591398A IL125913A0 IL 125913 A0 IL125913 A0 IL 125913A0 IL 12591398 A IL12591398 A IL 12591398A IL 12591398 A IL12591398 A IL 12591398A IL 125913 A0 IL125913 A0 IL 125913A0
- Authority
- IL
- Israel
- Prior art keywords
- cardio
- medicament
- inhibitor
- sodium
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19737224A DE19737224A1 (de) | 1997-08-27 | 1997-08-27 | Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL125913A0 true IL125913A0 (en) | 1999-04-11 |
Family
ID=7840257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12591398A IL125913A0 (en) | 1997-08-27 | 1998-08-24 | Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6348476B1 (sk) |
| EP (1) | EP0937464B1 (sk) |
| JP (1) | JP4436940B2 (sk) |
| KR (1) | KR19990023904A (sk) |
| CN (1) | CN1172665C (sk) |
| AR (1) | AR017513A1 (sk) |
| AU (1) | AU738598B2 (sk) |
| BR (1) | BR9803233A (sk) |
| CA (1) | CA2245776A1 (sk) |
| CZ (1) | CZ270998A3 (sk) |
| DE (1) | DE19737224A1 (sk) |
| HK (1) | HK1018211A1 (sk) |
| HR (1) | HRP980464A2 (sk) |
| HU (1) | HUP9801924A3 (sk) |
| IL (1) | IL125913A0 (sk) |
| NO (1) | NO320264B1 (sk) |
| NZ (1) | NZ331533A (sk) |
| PL (1) | PL195566B1 (sk) |
| RU (1) | RU2227751C2 (sk) |
| SK (1) | SK116798A3 (sk) |
| TR (1) | TR199801661A2 (sk) |
| TW (1) | TW589175B (sk) |
| ZA (1) | ZA987723B (sk) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19945302A1 (de) * | 1999-09-22 | 2001-03-29 | Merck Patent Gmbh | Biphenylderivate als NHE-3-Inhibitoren |
| US6423705B1 (en) | 2001-01-25 | 2002-07-23 | Pfizer Inc. | Combination therapy |
| IL147696A0 (en) * | 2001-01-25 | 2002-08-14 | Pfizer Prod Inc | Combination therapy |
| RU2004126702A (ru) * | 2002-02-04 | 2005-04-20 | АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) | Комбинированный препарат на основе ингибитора натрий-водородного обмена карипорида с ингибиторами ангиотензинконвертирующего фермента для предотвращения сердечной недостаточности и других, обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни |
| US6844361B2 (en) | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| US7375138B2 (en) * | 2002-05-18 | 2008-05-20 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
| FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
| US6878748B2 (en) | 2002-06-13 | 2005-04-12 | Aventis Pharma Deutschland Gmbh | Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them |
| US7629493B2 (en) * | 2003-05-06 | 2009-12-08 | Merck Patent Gmbh | Process for the crystallisation of guandinium salts |
| US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
| DE10356717A1 (de) * | 2003-12-02 | 2005-07-07 | Aventis Pharma Deutschland Gmbh | Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten |
| US7531569B2 (en) * | 2003-12-02 | 2009-05-12 | Sanofi-Aventis Deutschland Gmbh | Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| CA2586547A1 (en) * | 2004-11-05 | 2006-05-11 | King Pharmaceuticals Research & Development, Inc. | Stabilized individually coated ramipril particles, compositions and methods |
| US10517839B2 (en) | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| EP3960165A1 (en) * | 2020-08-25 | 2022-03-02 | Fondation EspeRare | Nhe-1 inhibitors for the treatment of coronavirus infections |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE158278T1 (de) | 1992-02-15 | 1997-10-15 | Hoechst Ag | Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
| EP0589336B1 (de) * | 1992-09-22 | 1997-01-08 | Hoechst Aktiengesellschaft | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
| DE4328869A1 (de) | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4421536A1 (de) | 1994-06-20 | 1995-12-21 | Hoechst Ag | Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4422685A1 (de) | 1994-06-29 | 1996-01-04 | Hoechst Ag | Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4432106A1 (de) | 1994-09-09 | 1996-03-14 | Hoechst Ag | Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung |
| DE19741635A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
-
1997
- 1997-08-27 DE DE19737224A patent/DE19737224A1/de not_active Withdrawn
-
1998
- 1998-08-21 EP EP98115754A patent/EP0937464B1/de not_active Expired - Lifetime
- 1998-08-24 IL IL12591398A patent/IL125913A0/xx not_active IP Right Cessation
- 1998-08-25 CA CA002245776A patent/CA2245776A1/en not_active Abandoned
- 1998-08-25 TR TR1998/01661A patent/TR199801661A2/xx unknown
- 1998-08-25 CZ CZ982709A patent/CZ270998A3/cs unknown
- 1998-08-25 SK SK1167-98A patent/SK116798A3/sk unknown
- 1998-08-25 NZ NZ331533A patent/NZ331533A/xx unknown
- 1998-08-25 BR BR9803233-0A patent/BR9803233A/pt not_active Application Discontinuation
- 1998-08-25 AR ARP980104222A patent/AR017513A1/es unknown
- 1998-08-26 HR HR19737224.4A patent/HRP980464A2/hr not_active Application Discontinuation
- 1998-08-26 AU AU81908/98A patent/AU738598B2/en not_active Ceased
- 1998-08-26 JP JP24020398A patent/JP4436940B2/ja not_active Expired - Fee Related
- 1998-08-26 HU HU9801924A patent/HUP9801924A3/hu unknown
- 1998-08-26 ZA ZA987723A patent/ZA987723B/xx unknown
- 1998-08-26 RU RU98116126/15A patent/RU2227751C2/ru not_active IP Right Cessation
- 1998-08-26 NO NO19983926A patent/NO320264B1/no unknown
- 1998-08-26 CN CNB981187013A patent/CN1172665C/zh not_active Expired - Fee Related
- 1998-08-27 PL PL328251A patent/PL195566B1/pl unknown
- 1998-08-27 KR KR1019980034758A patent/KR19990023904A/ko not_active Application Discontinuation
- 1998-10-07 TW TW087113939A patent/TW589175B/zh not_active IP Right Cessation
-
1999
- 1999-07-28 HK HK99103247A patent/HK1018211A1/xx not_active IP Right Cessation
-
2000
- 2000-07-05 US US09/610,425 patent/US6348476B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2245776A1 (en) | 1999-02-27 |
| RU2227751C2 (ru) | 2004-04-27 |
| PL195566B1 (pl) | 2007-10-31 |
| US6348476B1 (en) | 2002-02-19 |
| HU9801924D0 (en) | 1998-10-28 |
| JPH11139990A (ja) | 1999-05-25 |
| EP0937464A3 (de) | 2003-09-24 |
| ZA987723B (en) | 1999-03-01 |
| HUP9801924A3 (en) | 2004-11-29 |
| TR199801661A2 (xx) | 1999-03-22 |
| CZ270998A3 (cs) | 1999-03-17 |
| NO983926L (no) | 1999-03-01 |
| PL328251A1 (en) | 1999-03-01 |
| AU8190898A (en) | 1999-03-11 |
| AR017513A1 (es) | 2001-09-12 |
| CN1209316A (zh) | 1999-03-03 |
| NZ331533A (en) | 2000-04-28 |
| KR19990023904A (ko) | 1999-03-25 |
| BR9803233A (pt) | 2000-05-02 |
| NO320264B1 (no) | 2005-11-14 |
| HK1018211A1 (en) | 1999-12-17 |
| EP0937464A2 (de) | 1999-08-25 |
| TW589175B (en) | 2004-06-01 |
| DE19737224A1 (de) | 1999-03-18 |
| EP0937464B1 (de) | 2012-07-11 |
| JP4436940B2 (ja) | 2010-03-24 |
| HUP9801924A2 (hu) | 2000-02-28 |
| SK116798A3 (en) | 1999-03-12 |
| CN1172665C (zh) | 2004-10-27 |
| AU738598B2 (en) | 2001-09-20 |
| HRP980464A2 (en) | 1999-06-30 |
| NO983926D0 (no) | 1998-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL312064A1 (en) | Soft gelatinous form of pharmaceutical dose | |
| EP1045636A4 (en) | PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING THE SAME FOR TREATING FAILURE MYOCARDIAL TISSUES | |
| IL114586A (en) | Droloxifene for use in the treatment of cardiovascular diseases and pharmaceutical compositions comprising same | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| PL354168A1 (en) | Pharmaceutical composition of nateglinide and another antidiabetcagent | |
| IL125913A0 (en) | Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases | |
| AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
| EP1073416A4 (en) | USE OF INHAL NITRIC OXIDE AS ANTI-INFLAMMATORY AGENT | |
| EP1129217A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DISEASES | |
| HUP9802795A3 (en) | Pharmaceutical compositions containing beta-adrenergic agent and anorectic agent for the treatment of corpulence | |
| PL335555A1 (en) | Novel compounds - substituted benzamides and therapeutic agent | |
| HUP9700806A3 (en) | Matrix tablet allowing the prolonged release of the sodium salt of tianeptine and process for the preparation thereof | |
| IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
| HUP0000963A3 (en) | The use of levobupivacaine in paediatric surgery | |
| HUP0002719A3 (en) | Controlled release pharmaceutical preparation with ace inhibitor as active agent | |
| HUP0001263A3 (en) | Methods of therapeutic administration of anti-cd4ol compounds | |
| HUP0003679A3 (en) | Use of pkc inhibitors for the preparation of pharmaceutical compositions treating cardiovascular diseases | |
| HUP0001526A3 (en) | Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions | |
| GB2331926B (en) | Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine | |
| HUP0003074A3 (en) | Pharmaceutical composition comprising ssri and betha-blocking agent | |
| GB9304745D0 (en) | Use of pharmaceutical formulations | |
| AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
| EP0925791A4 (en) | PREVENTIVE AND / OR THERAPEUTICALLY ACTIVE SUBSTANCE FOR KIDNEY DISEASES | |
| GB9412995D0 (en) | Safety enhancing pharmaceutical compositions of an active indazole | |
| GB9817348D0 (en) | Pharmaceutical use of esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |